NSEUpdates5d ago · 1 Sept 2026, 04:29 pm
Updates
Symbiotec Pharmalab Limited · SYMBIOTEC
✦ AI SummaryRegulatory
Symbiotec Pharmalab Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulation 2015.' and enclosed the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Symbiotec Pharmalab Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities Exchange Board of India (Prohibition of Insider Trading) Regulation 2015.'.
Attachments (1)
📄pdf
Download →
SYMBIOTEC_01092026162906_Reg_8_2__Code_of_practice_UPSI.pdf
View document text
Date: September 01, 2026
Sr. General Manager Sr. General Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, C-1, Block G
Mumbai - 400001. Bandra -Kurla Complex, Bandra (East),
Mumbai- 400051.
Scrip Code: 544889 Scrip Symbol : SYMBIOTEC
ISIN: INE899I01028 ISIN: INE899I01028
Subject: Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of
Insider Trading) Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (‘SEBI PIT
Regulations’), please find enclosed herewith the Code of Practices and Procedures for Fair Disclosure of
Unpublished Price Sensitive Information framed under Regulation 8(1) of SEBI PIT Regulations.
This is for your information and record.
Thanking You,
For SYMBIOTEC PHARMALAB LIMITED
Salil Jain
Company Secretary and Compliance Officer
Membership No. A41610
Encl.: as Above
Registered Office & Works:
Symbiotec Pharmalab Limited
(Formerly known as Symbiotec Pharmalab Pvt. Ltd.)
385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India
Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222,
Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com
CIN: U24232MP2002PLC015293